-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Bolsa de Comercio de Buenos Aires-
Johnson & JohnsonBörse Börse FrankfurtISIN US4781601046EURSymbol JNJ
-
Johnson & JohnsonBörse Börse StuttgartEURSymbol JNJ
-
Johnson & JohnsonBörse Börse MünchenEURSymbol JNJ
-
Johnson & JohnsonBörse Börse BerlinEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Xetra FrankfurtEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Gettex System der Börse MünchenEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol JNJ
-
JOHNSON & JOHNSONBörse Quotrix System der Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse HamburgEURSymbol JNJ
-
USDJohnson & JohnsonBörse SGO
-
USDJohnson & JohnsonBörse BUE
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
Johnson & JohnsonBörse SSE
-
Marktkapitalisierung
99.567.000.000
Mitarbeiter
141.700
Aktionärsstruktur der Johnson & Johnson
Portrait der Johnson & Johnson Aktie
Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.
Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor MSCI USA Quality UCITS ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
3.033 News & Informationen zur Johnson & Johnson Aktie
Here’s Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month
A few weeks back, we discussed that Pfizer’s (NYSE: PFE) stock price could rebound over a one-month period after falling 4% in a week, based on its historical performance. However, PFE stock has seen a decline of over 6% since then, and it is down 4% in the last five trading days…
Here’s Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month
A few weeks back, we discussed that Pfizer’s (NYSE: PFE) stock price could rebound over a one-month period after falling 4% in a week, based on its historical performance. However, PFE stock has seen a decline of over 6% since then, and it is down 4% in the last five trading days…
Scientists continue to say there isn’t enough evidence to support giving COVID-19 boosters to all Americans
An influential Food and Drug Administration committee is set to meet Friday to discuss whether the regulator should approve BioNTech and Pfizer's COVID-19…
EDITION Continues To Build Powerhouse Leadership Team To Spearhead Unique Partnership Model
NEW YORK, Sept. 16, 2021 /PRNewswire/ — Today, EDITION, the first multi-platform portal into a world of luxury that celebrates talent from divers…
Iran approves U.S. firm J&J's shot as it fights fifth COVID wave By Reuters
Iran approves U.S. firm J&J's shot as it fights fifth COVID wave
PANDA responds to Geffen’s hit-piece on PANDA and its co-founder, Nick Hudson
PANDA addresses the assertions made by Nathan Geffen in his article on GroundUp, exposing them as baseless, ill-intentioned criticisms.
Will Johnson & Johnson Stock Rebound After A 4% Fall In A Week?
The stock price of Johnson & Johnson reached its all-time high of around $180 just last month before a recent sell-off in pharmaceutical stocks resulted in JNJ falling to $165 levels currently. Last month, we discussed that based on historical performance, there were higher chances of a decline…
Will Johnson & Johnson Stock Rebound After A 4% Fall In A Week?
The stock price of Johnson & Johnson reached its all-time high of around $180 just last month before a recent sell-off in pharmaceutical stocks resulted in JNJ falling to $165 levels currently. Last month, we discussed that based on historical performance, there were higher chances of a decline…
Three Billion and Counting: Pensa’s AI System Recognizes Products on Retail Shelves with 98 Percent Accuracy
AUSTIN, Texas, Sept. 16, 2021 (GLOBE NEWSWIRE) — Pensa Systems, a leading innovator in retail shelf intelligence, announced today that it has visually…
JNJ vs PG vs MMM for Dividends? : stocks
I'm looking into a solid stock for dividends. These 3 stocks are often highly recommended for this reason. MMM (3M) pays the biggest dividend @ …
Vaccinated Mr President? New York wants proof, UN chief cannot enforce
Dozens of heads of state and government and foreign ministers – accompanied by countless diplomats – are due to be in New York next week for an annual high-level gathering at the United Nations. Some leaders are staying away and sending a video statement instead because of the coronavirus pandemic.
China's biotech sector comes of age with big licensing deals, global ambitions
HONG KONG — If investors in China’s biotech industry needed one more sign that the sector is coming of age, then a major licensing deal RemeGen Co Ltd struck…
Vaccinated Mr President? New York wants proof, U.N. chief cannot enforce By Reuters
Vaccinated Mr President? New York wants proof, U.N. chief cannot enforce
Analysis-China's biotech sector comes of age with big licensing deals, global ambitions By Reuters
Analysis-China's biotech sector comes of age with big licensing deals, global ambitions
International Payroll Management Solutions Provider Papaya Global Raised $250M In Series D Funding
The funding helps bring Papaya Global to a $3.7B valuation. Here are the top-line bullets you need to know.
FDA strikes cautious tone ahead of vaccine booster meeting
Influential government advisers will debate Friday if there's enough proof that a booster dose of Pfizer's COVID-19 vaccine is safe and effective — the first step toward deciding which Americans need one and when.
Johnson & Johnson (JNJ) Management Presents on Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
Johnson & Johnson (NYSE:JNJ) Morgan Stanley 19th Annual Global Healthcare Conference Call September 15, 2021 09:30 ET Company Participants Joseph Wolk – Executive Vice President &…
For the next pandemic, we’ll have gigantic mRNA factories in India: Bill Gates
“Now that the world understands its vulnerability to a pandemic, there will be a huge amount of research and invention of new tools. The diagnostics – we could scale that up much faster. The therapeutics we could do a lot better. We should have a goal that we have so much factory capacity that, even within 200 days, we could make enough vaccines for the entire world,” Gates said.
Impfen! Impfen! Impfen! – Wenn Lehrer Schüler zum Impfen drängen
Von Michael Friese | Seit dem Ausbruch von Corona hat vermutlich jeder schon mal Seiten an seinen Kumpels oder Familienmitgliedern entdeckt, von denen man nicht gedacht hätte, dass sie bei ihnen ex…
The US could authorize COVID-19 vaccines for younger kids by Halloween, Pfizer's new timeline suggests
Pfizer expects to submit data to the FDA that shows how well its vaccine performs among kids ages 5 to 11 in early October.
The District’s business incentives should target its comparative advantages
The District’s business incentives should target its comparative advantages – D.C. Policy Center
15 Dividend Stocks People Buy for Early Retirement
In this article, we will be taking a look at 15 dividend stocks people buy for early retirement.
Global Vessel Sealing Devices Markets, 2021-2028: Market to Reach $2.4 Billion at a CAGR of Over 8%
/PRNewswire/ — The
Autolus Therapeutics Announces The Appointment Of John H. Johnson As Non-executive Chairman Of Its Board Of Directors
LONDON, Sept. 15, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation
Stroke management Market revenue to cross USD 48.5 Bn by 2027: Global Market Insights Inc.
APAC stroke management market is estimated to attain a CAGR of 6.6% through 2027 led by the increasing prevalence of acute ischemic stroke. …
Children’s Health Defense Responds to Biden’s ‘Declaration of War Against the Unvaccinated’
President Biden’s speech last week was stunning. As the Associated Press aptly reported, the president pivoted from a war on the coronavirus to a war on the “unvaccinated.” Coercing the “unvaccinated” was the president’s first and foremost point — the only way back to normal is through vaccination, testing and masks, he said. But the president went much further — he vilified the unvaccinated. They are not “doing the right thing.” They are “keeping us from turning the corner.” They are “blocking public health.” “The refusal [of the unvaccinated] has cost all of us,” Biden said. Addressing the 80 million refusers, the president said, … Continue reading →
U.S. administers 381.5 million doses of COVID-19 vaccines -CDC By Reuters
U.S. administers 381.5 million doses of COVID-19 vaccines -CDC
Can Ketamine For Depression Be Improved? New Study Will Looks Into Ketamine Analog Arketamine – ATA (ATAI)
Perception Neuroscience, an Atai Life Sciences (NASDAQ:ATAI) subsid…
5 Top Dividend Aristocrats to Beef Up Your Portfolio
The 65-member Dividend Aristocrats are among the market's best sources of reliable, predictable income. But these five stand out as truly elite.
With Market Size Valued At $966.4 Million By 2026, It`s A Healthy Outlook For The Global Mouth Fresheners Market
SAN FRANCISCO, Sept. 14, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
J&J reports promising Ebola vaccine data
Johnson & Johnson said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet…
Washington hospital execs: little capacity to help Idaho
Washington is facing its own COVID-19 crisis and has little capacity to help neighboring Idaho deal with an overwhelming surge of cases driven by unvaccinated people, state hospital executives and doctors said Monday.
Providence licenses mRNA technology to China's Everest in $100-million deal
Calgary-based Providence has secured rights to stock and profit sharing totalling up to $400 million, plus royalties, if certain milestones are met
Florida Gov. Ron DeSantis let a man falsely claim the COVID vaccine 'changes your RNA' during an anti-vaccine mandate press conference
DeSantis' spokesperson, Taryn Fenske, told Insider the governor
ASX Today: US cyclicals shine as Covid cases decline
Aussie stocks looked set to open lower after Wall Street broke a…
In Malawi, COVID-19 Vaccines Delivered By COVAX Protect Frontline Workers
Keeping essential workers safe from COVID-19 is a priority in Malawi, where less than 3% of the population is fully vaccinated.
Gurus Continue Buying Alibaba Despite China Crackdown
GuruFocus Article or News written by James Li and the topic is about: Shares of Alibaba fall as Beijing plans to break up Alipay
Kimberly-Clark Names Doug Cunningham To Lead Its EMEA Consumer Business
DALLAS, Sept. 13, 2021 /PRNewswire/ — Kimberly-Clark Corporation KMB today announced that Doug Cunningham, currently Managing Director of Kimberly-Clark
Worldwide Anti-Tumor Drugs Industry To 2026 – Growing Awareness Regarding Early Diagnosis And Treatment For Cancer Is Driving The Market
DUBLIN, Sept. 13, 2021 The “Anti-Tumor Drugs Market Research Report by Indications, by Drug Class, by End User, by Route of Administration, by Distribution
mRNA vaccines not linked to miscarriage; COVID-19 shots in U.S. still protect against severe disease
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet…